88S30011 MPF-F
 
  By: Gervin-Hawkins H.B. No. 140
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the establishment of the Neurodegenerative Disease
  Advisory Committee.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 154.001, Education Code, is amended to
  read as follows:
         Sec. 154.001.  DEFINITIONS [DEFINITION]. In this chapter:
               (1)  "Advisory committee" means the Neurodegenerative
  Disease Advisory Committee.
               (2)  "Council[, "council]" means the Texas Council on
  Alzheimer's Disease and Related Disorders.
         SECTION 2.  Chapter 154, Education Code, is amended by
  adding Section 154.0045 to read as follows:
         Sec. 154.0045.  NEURODEGENERATIVE DISEASE ADVISORY
  COMMITTEE. (a) The council shall establish the Neurodegenerative
  Disease Advisory Committee to:
               (1)  support the consortium of Alzheimer's disease
  centers through the council's Darrell K Royal Texas Alzheimer's
  Initiative in:
                     (A)  discovering the causes of Alzheimer's
  disease and other neurodegenerative diseases in humans;
                     (B)  developing cures for those diseases; and
                     (C)  establishing programs to address access to
  advanced treatment of Alzheimer's disease; and
               (2)  establish appropriate standards consistent with
  the powers and duties of the consortium under this chapter to ensure
  the proper use of money authorized for Alzheimer's disease
  research, facilities development, and caregiver resources.
         (b)  The advisory committee is composed of the following nine
  members:
               (1)  one member appointed by the governor who is a
  member of the Board of Advisors for the Darrell K Royal Research
  Fund for Alzheimer's Disease;
               (2)  four members appointed by the lieutenant governor;
  and
               (3)  four members appointed by the speaker of the house
  of representatives.
         (c)  In appointing members to the advisory committee under
  Subsections (b)(2) and (3), the lieutenant governor and the speaker
  of the house of representatives must each appoint:
               (1)  three individuals who are physicians or scientists
  with extensive experience in the field of Alzheimer's disease and
  neurology, including at least one individual who represents a
  nationally designated Alzheimer's disease research center funded
  by the National Institute on Aging; and
               (2)  one member of the public.
         (d)  The member appointed by the governor under Subsection
  (b)(1) serves as chair of the advisory committee.
         (e)  The members of the advisory committee serve staggered
  three-year terms. The appointing authorities shall appoint the
  initial member to terms of one, two, and three years as necessary to
  ensure one-third of the appointed members' terms expire each year.
         (f)  The members of the advisory committee serve at the
  pleasure of the appointing authority.
         (g)  If a vacancy occurs on the advisory committee, the
  appropriate appointing authority shall appoint a successor in the
  same manner as the original appointment to serve for the remainder
  of the unexpired term. The appropriate appointing authority shall
  appoint the successor not later than the 30th day after the date the
  vacancy occurs.
         (h)  The council shall hire personnel as necessary to support
  the advisory committee in fulfilling its duties under this chapter.
         (i)  Section 2110.008, Government Code, does not apply to the
  advisory committee.
         SECTION 3.  Not later than March 1, 2024, the governor,
  lieutenant governor, and speaker of the house of representatives
  shall appoint members of the Neurodegenerative Disease Advisory
  Committee established under Section 154.0045, Education Code, as
  added by this Act.
         SECTION 4.  This Act takes effect on the 91st day after the
  last day of the legislative session.